Home>Topics>>Dutch drugmaker Prosensa jumps 54 percent in U.S. stock market debut

Dutch drugmaker Prosensa jumps 54 percent in U.S. stock market debut

Reuters: Global Markets

Fri, 28 Jun 2013

(Reuters) - Dutch drugmaker Prosensa Holding received a buoyant welcome in its market debut on the Nasdaq, a day after U.S. health regulators granted a "breakthrough status" to its drug to treat a...

Related Topics:

  2. Netherlands
  3. Stock Market

Related Videos

  1. Special Report: Investing in a Volatile World

    Tue, 2 Jul 2013

    Morningstar's top strategists discuss their tips for investing in a rising-rate environment, where equity values lie, and some of their favorite investment ideas right now in this special midyear roundtable.

  2. A Strong Economy Doesn't Equal Strong Returns

    Thu, 18 Oct 2012

    There is effectively zero correlation over long periods of time between a country's GDP growth and stock market returns, according to Vanguard chief economist Joe Davis.

  3. Bogle: The Problems With 401(k)s

    Thu, 13 Jun 2013

    The 401(k) is really a thrift plan that we've tried to redesign into a retirement plan, and it needs to change, says the Vanguard founder.

  4. Hard to Be Upset About Stocks

    Wed, 17 Jul 2013

    U.S. and most foreign equities saw strong growth during the first half of 2013, but this healthy bull market could be a ripe time for investors to rebalance their portfolios.

Content Partners